Illinois members of Congress say they were denied access to an ICE facility for second day
U.S. Reps. Delia Ramirez, Jesús "Chuy" García, Jonathan Jackson, and Danny Davis went to a U.S. Immigration and Customs Enforcement processing center in Broadview Wednesday. The members of Congress said they have heard reports that the facility is being used as a detention center, in violation of state and city ordinances.
The members of Congress also said they wanted to confirm reports that migrants held there are facing inhumane conditions and being cut off from their attorneys.
The representatives held a news conference after García said the group was denied entry, despite federal law allowing them to inspect it.
"What is happening in that detention facility, we should be able to inspect," said Jackson.
"Members of Congress with the authority to be able to conduct unannounced oversight were told through a hole in a gate of barbed wire, 'Send an email,'" added Ramirez.
This comes one day after Reps. Jackson and Raja Krishnamoorthi were also turned away from an immigration facility in Chicago's South Loop.
CBS News Chicago reached out to ICE on this matter Wednesday, but had not heard back as of the afternoon.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
Exclusive-US pharma tariffs likely weeks away as Trump plans for Alaska, sources say
By Maggie Fick, Andrea Shalal and Dave Graham WASHINGTON (Reuters) -The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new sector-specific U.S. tariffs likely remains weeks away, four official and industry sources said, later than initially promised as he focuses on other matters. Commerce Secretary Howard Lutnick had said in April when the review of whether reliance on foreign drug production threatens U.S. national security was launched that he anticipated that it would conclude between mid-May and mid-June. Global pharmaceutical companies are bracing for the outcome of the investigation, which will usher in sector-specific tariffs that Trump has said could start small and eventually rise to 250%. The Republican president said as recently as last week that his plan relies on phased-in tariffs, giving drugmakers time to increase manufacturing in the United States as he pushes to alter what he says are global trade distortions in many industries. One government official in Europe and a source with knowledge of the White House process, as well as two sources at European drug firms familiar with the process, told Reuters that the report and tariffs announcement was not imminent and likely weeks away. These sources spoke on condition of anonymity. A White House spokesperson, asked about media reporting indicating that the results of the probe could be several weeks away, cautioned that such reports were pure speculation unless confirmed by the White House. The spokesperson declined to give further details about the timing of the pharma probe or one involving semiconductors. The investigation is examining pharmaceutical imports ranging from finished prescription drugs to active pharmaceutical ingredients, called APIs, and other raw materials, with the results to be disclosed in a Commerce Department report. Lutnick said last month the tariff plan that will be based on the report would be completed by the end of July. Lutnick then said on July 29 it would be two more weeks. The investigation was launched under Section 232 of the Trade Expansion Act of 1962. While the investigation is ongoing, the pharmaceutical sector has been exempted from the sweeping tariffs imposed by the Trump administration. The United States has reached bilateral trade deals with the UK, Japan, South Korea and the European Union that promised more favorable terms for their pharma exports than those expected to be levied on the sector globally. A European government official said that an announcement before the end of August appears unlikely but cautioned that the timeline could shift depending on other developments. A source at a European drugmaker said the Trump administration is focused on the U.S.-Russia summit in Alaska on Friday and therefore no announcement is expected this week. The source familiar with the White House process said that announcement is unlikely to come this week given other priorities. That source and one other source said that they expect the Trump administration to announce the results of its national security investigation into semiconductors first, followed by the pharma announcement, putting it a few weeks away. The Section 232 provision authorizes the president to adjust imports - including imposing tariffs - if a category of goods is being imported into the United States in quantities that "threaten or impair the national security." Medical goods historically have been spared from trade wars due to the potential harm to patient access, and drugmakers have said tariffs could undercut other health policy goals outlined by the Trump administration, including lowering drug prices. U.S. tariffs on imported pharmaceutical products would mark the latest in a series of sectoral tariffs announced by the administration, following metals and cars, that some economists have predicted will drive up costs for American consumers.
San Francisco Chronicle
3 minutes ago
- San Francisco Chronicle
ICE arrests 6 people in Oakland home, including a minor, attorney says
Federal immigration officers raided an East Oakland home on Tuesday and detained at least six people, including a minor and a person with a severe disability, according to an immigration attorney. ICE officers made the arrests at a home near 79th Avenue and Hillside Street on Tuesday morning after a person inside slightly opened the door, said Nikolas De Bremaeker, an attorney at Centro Legal de la Raza and the Alameda County Rapid Response Network. Six people, including a 17-year-old, from multiple Central American countries were arrested and taken to the ICE field office in San Francisco. Some of them were siblings, De Bremaeker said. It was not immediately known if the detainees had any criminal histories, he said. De Bremaeker condemned ICE officials for detaining the 17-year-old at its field office because he said it does not meet the criterion of the Flores Settlement Agreement, which established decades-long standards for detaining children in safe and sanitary facilities. 'The ICE field office is definitely not an appropriate location for a child to be,' De Bremaeker said. The child remained at the field office on Wednesday morning despite De Bremaeker alerting ICE officials of the Flores Settlement Agreement's standards and being told that the child would be transferred to another location, De Bremaeker said. The arrests on Tuesday do not appear to be the first confirmed ICE activity in Oakland. In June, Oakland police confirmed to the Chronicle that ICE alerted them of its activity but ICE did not provide additional details. Oakland Mayor Barbara Lee on Wednesday encouraged people who witness ICE activity or need legal assistance to contact Alameda County's hotline at 510-241-4011. 'Trump's dangerous immigration policies are designed to terrorize families and divide communities, not enhance public safety. When families live in fear, our entire community is less safe. Oakland remains a sanctuary city that protects our immigrant neighbors and keeps our communities whole,' she said in a statement.
CBS News
4 minutes ago
- CBS News
Appeals court allows Trump administration to cut billions in foreign aid
Washington — A divided panel of appeals court judges ruled Wednesday that the Trump administration can suspend or terminate billions of dollars of congressionally appropriated funding for foreign aid. Two of three judges from the U.S. Court of Appeals for the District of Columbia Circuit concluded that grant recipients challenging the freeze did not meet the requirements for a preliminary injunction that restored the flow of money. In January, on the first day of his second term in the White House, President Trump issued an executive order directing the State Department and the U.S. Agency for International Development to freeze spending on foreign aid. After groups of grant recipients sued to challenge that order, U.S. District Judge Amir Ali ordered the administration to release the full amount of foreign assistance that Congress had appropriated for the 2024 budget year. The appeal court's majority partially vacated Ali's order. Judges Karen LeCraft Henderson and Gregory Katsas concluded that the plaintiffs did not have a valid legal basis for the court to hear their claims. The ruling was not on the merits of whether the government unconstitutionally infringed on Congress' spending powers. "The parties also dispute the scope of the district court's remedy but we need not resolve it ... because the grantees have failed to satisfy the requirements for a preliminary injunction in any event," Henderson wrote. Judge Florence Pan, who dissented, said the Supreme Court has held "in no uncertain terms" that the president does not have the authority to disobey laws for policy reasons. "Yet that is what the majority enables today," Pan wrote. "The majority opinion thus misconstrues the separation-of-powers claim brought by the grantees, misapplies precedent, and allows Executive Branch officials to evade judicial review of constitutionally impermissible actions." The money at issue includes nearly $4 billion for USAID to spend on global health programs and more than $6 billion for HIV and AIDS programs. Mr. Trump has portrayed the foreign aid as wasteful spending that does not align with his foreign policy goals. Henderson was nominated to the court by Republican President George H.W. Bush. Katsas was nominated by Trump. Pan was nominated by Democratic President Joe Biden.
